ATE149031T1 - Pyridinderivate - Google Patents
PyridinderivateInfo
- Publication number
- ATE149031T1 ATE149031T1 AT90303708T AT90303708T ATE149031T1 AT E149031 T1 ATE149031 T1 AT E149031T1 AT 90303708 T AT90303708 T AT 90303708T AT 90303708 T AT90303708 T AT 90303708T AT E149031 T1 ATE149031 T1 AT E149031T1
- Authority
- AT
- Austria
- Prior art keywords
- pyridine derivatives
- formula
- agonists
- antihypertensives
- heteroaromatic
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 208000022531 anorexia Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- -1 heteroaromatic N-oxides Chemical class 0.000 abstract 1
- 239000004031 partial agonist Substances 0.000 abstract 1
- 150000003222 pyridines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898907865A GB8907865D0 (en) | 1989-04-07 | 1989-04-07 | Tetrahydroquinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE149031T1 true ATE149031T1 (de) | 1997-03-15 |
Family
ID=10654625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90303708T ATE149031T1 (de) | 1989-04-07 | 1990-04-06 | Pyridinderivate |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5075303A (de) |
| EP (1) | EP0395244B1 (de) |
| JP (1) | JP2945064B2 (de) |
| KR (1) | KR0156569B1 (de) |
| AT (1) | ATE149031T1 (de) |
| AU (1) | AU625845B2 (de) |
| CA (1) | CA2014062C (de) |
| DD (1) | DD298391A5 (de) |
| DE (1) | DE69029954T2 (de) |
| DK (1) | DK0395244T3 (de) |
| ES (1) | ES2099703T3 (de) |
| FI (1) | FI95373C (de) |
| GB (2) | GB8907865D0 (de) |
| GR (1) | GR3023396T3 (de) |
| HK (1) | HK121994A (de) |
| HU (1) | HU217128B (de) |
| IE (1) | IE63627B1 (de) |
| IL (1) | IL94011A (de) |
| NZ (1) | NZ233222A (de) |
| PH (1) | PH27590A (de) |
| PT (1) | PT93673B (de) |
| ZA (1) | ZA902662B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5273994A (en) * | 1990-04-09 | 1993-12-28 | Adir Et Compagnie | 3-aminochroman compounds |
| FR2660657B1 (fr) * | 1990-04-09 | 1993-05-07 | Adir | Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| GB9019942D0 (en) * | 1990-09-12 | 1990-10-24 | Wyeth John & Brother Ltd | Azetidine derivatives |
| US5532243A (en) * | 1992-02-14 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Antipsychotic nitrogen-containing bicyclic compounds |
| GB9304632D0 (en) * | 1993-03-06 | 1993-04-21 | Wyeth John & Brother Ltd | Amide derivatives |
| EP0743855A1 (de) * | 1994-01-03 | 1996-11-27 | Acea Pharmaceuticals, Inc. | 8-Aza,6-Aza und 6,8-Diaza - 1,4 dihydrochinoxalin -2,3-dione und deren Verwendung als Glycin/NMDARezeptor Antagonisten |
| US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
| US6180632B1 (en) * | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US7105513B2 (en) * | 2002-08-07 | 2006-09-12 | Sanofi-Avertis Deutschland Gmbh | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| JP5770158B2 (ja) * | 2009-03-23 | 2015-08-26 | シプラ・リミテッド | ドキサゾシン及びその塩の製造方法 |
| KR101987514B1 (ko) * | 2011-10-18 | 2019-06-10 | 아스텔라스세이야쿠 가부시키가이샤 | 이환식 헤테로환 화합물 |
| AU2015240774B2 (en) * | 2014-04-01 | 2019-08-15 | Howard Hughes Medical Institute | Azetidine-substituted fluorescent compounds |
| US12440581B2 (en) | 2019-09-19 | 2025-10-14 | Howard Hughes Medical Institute | Fluorophores for super-resolution imaging |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH566315A5 (de) * | 1972-04-04 | 1975-09-15 | Ciba Geigy Ag | |
| GB1463582A (en) * | 1974-03-05 | 1977-02-02 | Wyeth John & Brother Ltd | Pyridine derivatives |
| GB1463583A (en) * | 1974-03-05 | 1977-02-02 | Wyeth John & Brother Ltd | Halo and hydroxy compounds |
| DK309678A (da) * | 1977-07-18 | 1979-01-19 | Sandoz Ag | Fremgangsmaade til fremstilling af tetralinderivater |
| SE8004002L (sv) * | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
| DK111387A (da) * | 1986-03-05 | 1987-09-06 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne |
| US4748182A (en) * | 1986-03-05 | 1988-05-31 | Merrell Dow Pharmaceuticals Inc. | Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents |
| JPS63107990A (ja) * | 1986-05-14 | 1988-05-12 | Nippon Shinyaku Co Ltd | キノリンカルボン酸誘導体 |
| DE3718317A1 (de) * | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| US4878941A (en) * | 1987-12-29 | 1989-11-07 | Fmc Corporation | Herbicides |
| US4894084A (en) * | 1987-12-29 | 1990-01-16 | Fmc Corporation | Substituted quinolinonyl and dihydroquinolinonyl triazolinone herbicides |
-
1989
- 1989-04-07 GB GB898907865A patent/GB8907865D0/en active Pending
-
1990
- 1990-04-05 PT PT93673A patent/PT93673B/pt not_active IP Right Cessation
- 1990-04-05 IL IL9401190A patent/IL94011A/en not_active IP Right Cessation
- 1990-04-05 AU AU52971/90A patent/AU625845B2/en not_active Ceased
- 1990-04-05 ZA ZA902662A patent/ZA902662B/xx unknown
- 1990-04-05 NZ NZ233222A patent/NZ233222A/en unknown
- 1990-04-06 GB GB9007889A patent/GB2230007B/en not_active Expired - Fee Related
- 1990-04-06 ES ES90303708T patent/ES2099703T3/es not_active Expired - Lifetime
- 1990-04-06 KR KR1019900004697A patent/KR0156569B1/ko not_active Expired - Fee Related
- 1990-04-06 FI FI901761A patent/FI95373C/fi not_active IP Right Cessation
- 1990-04-06 DE DE69029954T patent/DE69029954T2/de not_active Expired - Fee Related
- 1990-04-06 HU HU902108A patent/HU217128B/hu not_active IP Right Cessation
- 1990-04-06 IE IE125290A patent/IE63627B1/en not_active IP Right Cessation
- 1990-04-06 US US07/505,957 patent/US5075303A/en not_active Expired - Lifetime
- 1990-04-06 DK DK90303708.3T patent/DK0395244T3/da active
- 1990-04-06 JP JP2092961A patent/JP2945064B2/ja not_active Expired - Fee Related
- 1990-04-06 EP EP90303708A patent/EP0395244B1/de not_active Expired - Lifetime
- 1990-04-06 AT AT90303708T patent/ATE149031T1/de not_active IP Right Cessation
- 1990-04-06 CA CA002014062A patent/CA2014062C/en not_active Expired - Fee Related
- 1990-04-06 PH PH40345A patent/PH27590A/en unknown
- 1990-04-06 DD DD90339534A patent/DD298391A5/de unknown
-
1994
- 1994-11-03 HK HK121994A patent/HK121994A/xx not_active IP Right Cessation
-
1997
- 1997-05-09 GR GR970401050T patent/GR3023396T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH27590A (en) | 1993-08-18 |
| GB2230007A (en) | 1990-10-10 |
| IL94011A (en) | 1994-06-24 |
| IE63627B1 (en) | 1995-05-17 |
| HU902108D0 (en) | 1990-08-28 |
| ZA902662B (en) | 1991-02-27 |
| EP0395244B1 (de) | 1997-02-19 |
| FI901761A0 (fi) | 1990-04-06 |
| KR900016138A (ko) | 1990-11-12 |
| AU625845B2 (en) | 1992-07-16 |
| DK0395244T3 (da) | 1997-03-17 |
| HUT54658A (en) | 1991-03-28 |
| JPH02290852A (ja) | 1990-11-30 |
| DE69029954D1 (de) | 1997-03-27 |
| GR3023396T3 (en) | 1997-08-29 |
| CA2014062A1 (en) | 1990-10-07 |
| AU5297190A (en) | 1990-10-11 |
| CA2014062C (en) | 2000-06-13 |
| FI95373C (fi) | 1996-01-25 |
| EP0395244A1 (de) | 1990-10-31 |
| KR0156569B1 (ko) | 1998-11-16 |
| GB9007889D0 (en) | 1990-06-06 |
| GB8907865D0 (en) | 1989-05-24 |
| US5075303A (en) | 1991-12-24 |
| ES2099703T3 (es) | 1997-06-01 |
| NZ233222A (en) | 1991-07-26 |
| HU217128B (hu) | 1999-11-29 |
| GB2230007B (en) | 1992-10-14 |
| PT93673A (pt) | 1990-11-20 |
| DD298391A5 (de) | 1992-02-20 |
| JP2945064B2 (ja) | 1999-09-06 |
| FI95373B (fi) | 1995-10-13 |
| DE69029954T2 (de) | 1997-05-28 |
| PT93673B (pt) | 1996-08-30 |
| HK121994A (en) | 1994-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA21778A1 (fr) | Procede d'obtention de derives de n - ( 3-hydroxy-4 piperidinyl ) dihydro-benzofuranne, dihydro-2h- ,benzopyranne ou dihydro benzodioxin ) carboxamide . | |
| ES2130116T3 (es) | Derivados de piperazina. | |
| DK73193A (da) | Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner | |
| DE69014393D1 (de) | Heterocyclische N-Oxid-Derivate substituierter Benzo[5,6]cycloheptapyridine, Zusammensetzungen und Methoden der Verwendung. | |
| DE69029954D1 (de) | Pyridinderivate | |
| DE3777735D1 (de) | Imid-derivate, ihre herstellung und ihre verwendung. | |
| HUT59394A (en) | Process for producing piperazine derivatives and pharmaceutical compositions comprising same | |
| NO930284L (no) | Pyridinderivater, fremgangsmaate for deres fremstilling oganvendelse derav | |
| DK0381114T3 (da) | Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf | |
| ATE78154T1 (de) | Salz von 6-(1-piperidinyl-)2,4-diaminopyrimidin-3-oxyd und acetylaminoessigsaeure deren herstellung und deren dermatokosmetische verwendung. | |
| ATE45356T1 (de) | Pyridinderivate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |